Microdosing GLP-1s: What the Evidence Actually Says
Microdosing GLP-1s for prescribers: what the dose-response data actually show, why compounded microdose product is restricted, and how to counsel requests.
Microdosing GLP-1s for prescribers: what the dose-response data actually show, why compounded microdose product is restricted, and how to counsel requests.
Oral semaglutide 25 mg for weight management: the administration rules that govern absorption, monthly titration, efficacy vs. injection, and ideal candidates.
Tirzepatide titration for weight management: the 2.5 to 15 mg dose ladder, the four-week rule, choosing a maintenance dose and the 4-day missed-dose rule.
Tirzepatide vs. semaglutide for prescribers: SURMOUNT-5 head-to-head data, mechanism, dosing, tolerability and cost, plus how to match agent to patient.
Tirzepatide vs. semaglutide for prescribers: SURMOUNT-5 head-to-head data, mechanism, dosing, tolerability and cost, plus how to match agent to patient.
GLP-1 contraindications for prescribers: the two absolute rules, the relative cautions, a pre-prescribing screen, special populations and key interactions.
How GLP-1 agonists work: receptor targets, the brain pathways that cut appetite, slowed gastric emptying and glucose-dependent insulin release, for prescribers.

Obesity ICD-10 codes, CPT and HCPCS for 2026 weight-loss programs, plus documentation, denial fixes, Medicare GLP-1 Bridge coverage and cash-pay models.

Obesity ICD-10 codes, CPT and HCPCS for 2026 weight-loss programs, plus documentation, denial fixes, Medicare GLP-1 Bridge coverage and cash-pay models.

We know starting a new aesthetics practice or medspa can be scary, especially if you’re new to the field!
That’s why we’ve put together this helpful guide to take you through some of the important points of starting your new practice.
Terms and conditions apply. Offer expires October 31.